Infectious complications in non-myeloablative conditioning and allogeneic peripheral blood stem cell transplantation for patients with multiple myeloma.

被引：0
|
作者：
Lee, CK
Dignani, C
Barlogie, B
Guido, T
Morris, CL
Badros, AZ
Cottler-Fox, MH
van Rhee, F
Zanagari, M
Fassas, A
Anaissie, EJ
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Hosp Clin Sao Paulo, Sao Paulo, Brazil
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Loma Linda Univ, Med Ctr, Loma Linda, CA 92350 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2471
引用
收藏
页码：627A / 627A
页数：1
相关论文
共 50 条
  • [21] Non-myeloablative allogeneic transplantation with adjuvant dose escalated donor lymphocyte infusions for multiple myeloma.
    Peggs, KS
    Williams, CD
    Chopra, R
    D'Sa, S
    Thuraisundaram, D
    Schey, S
    Craddock, C
    Parker, A
    Goldstone, AH
    Mackinnon, S
    Yong, K
    BLOOD, 2000, 96 (11) : 781A - 781A
  • [22] Planned sequential autologous/non-myeloablative allogeneic peripheral stem cell transplantation in patients with newly diagnosed high-risk multiple myeloma
    Zinke-Cerwenka, W
    Neumeister, P
    Eibl, M
    Sill, H
    Emberger, W
    Wagner, T
    Wölfler, A
    Linkesch, W
    BONE MARROW TRANSPLANTATION, 2005, 35 : S387 - S388
  • [23] Quality of life in patients undergoing non-myeloablative (NST) versus myeloablative (MT) allogeneic peripheral blood stem cell transplantation (PBSCT).
    Bevans, M
    Marden, S
    Leidy, N
    Soeken, K
    Rivera, P
    Cusack, G
    Mayberry, H
    Bishop, M
    Barrett, J
    BLOOD, 2003, 102 (11) : 722A - 722A
  • [24] Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Mackinnon, S
    Kottaridis, P
    Perry, A
    Chakrabarti, S
    Milligan, DW
    Pettengell, R
    Chopra, R
    Morgan, G
    Hale, G
    Waldmann, H
    Linch, DC
    Devereux, S
    Goldstone, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 31 - 31
  • [25] GVHD and CMV antigenemia after allogeneic peripheral blood stem cell transplantation: Comparison between myeloablative and non-myeloablative (MINI) conditioning regimens.
    Reddy, V
    Pollock, BH
    Sharda, S
    Hopkins, J
    Weeks, F
    Manion, K
    Roque, D
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Mehta, P
    Moreb, JS
    Wingard, JR
    BLOOD, 2000, 96 (11) : 191A - 191A
  • [26] ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) WITH NON-MYELOABLATIVE CONDITIONING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS
    Novarino, A.
    Busca, A.
    Falda, M.
    Locatelli, F.
    Rossi, G.
    Galetto, A.
    Serra, A.
    Scaravaglio, P.
    Gallo, E.
    Ottaviani, D.
    Bertetto, O.
    ANNALS OF ONCOLOGY, 2004, 15 : 77 - 77
  • [27] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    P Campbell
    P Walker
    S Avery
    S Patil
    D Curtis
    A Schwarer
    A Wei
    A Kalff
    J Muirhead
    A Spencer
    Blood Cancer Journal, 2014, 4 : e213 - e213
  • [28] Treosulfan/fludarabine as conditioning regimen for allogeneic stem cell transplantation in multiple myeloma.
    Knauf, WU
    Blau, W
    Ruutu, T
    Einsele, H
    Thiel, E
    Freund, M
    Casper, J
    BLOOD, 2003, 102 (11) : 711A - 711A
  • [29] Infections after allogeneic haematopoietic stem cell transplantation with a non-myeloablative conditioning regimen
    Frere, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S164 - S164
  • [30] Analysis of immune reconstitution in adults undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation
    Guo, HF
    Qiao, ZH
    Su, LP
    Zhu, L
    Wang, HW
    Ma, LM
    HAEMATOLOGICA, 2003, 88 (07) : 833 - 835
12345